These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3654972)

  • 1. Demonstration of 2-hydroxybenzoylglycine as a drug binding inhibitor in newborn infants.
    Suh B; Wadsworth SJ; Lichtenwalner DM
    J Clin Invest; 1987 Oct; 80(4):1125-31. PubMed ID: 3654972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and chemical characterization of 2-hydroxybenzoylglycine as a drug binding inhibitor in uremia.
    Lichtenwalner DM; Suh B; Lichtenwalner MR
    J Clin Invest; 1983 May; 71(5):1289-96. PubMed ID: 6853715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast milk jaundice: an in vitro study of the effect of free fatty acids on the bilirubin-serum albumin complex.
    Yong FC; Cheah SS
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):679-88. PubMed ID: 561427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling of endogenous ligand solutes that bind to serum proteins in sera of patients with uremia.
    Mabuchi H; Nakahashi H
    Nephron; 1986; 43(2):110-6. PubMed ID: 3086761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro displacement of bilirubin by antibiotics and 2-hydroxybenzoylglycine in newborns.
    Wadsworth SJ; Suh B
    Antimicrob Agents Chemother; 1988 Oct; 32(10):1571-5. PubMed ID: 3190184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein binding of ceftriaxone: comparison of three techniques of determination and the effect of 2-hydroxybenzoylglycine, a drug-binding inhibitor in uremia.
    Fiset C; Vallée F; LeBel M; Bergeron MG
    Ther Drug Monit; 1986; 8(4):483-9. PubMed ID: 3824437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 2-hydroxybenzoylglycine on bilirubin-albumin binding.
    Robertson A; Karp W
    Pharmacol Toxicol; 1988 Nov; 63(5):400-1. PubMed ID: 3237597
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial purification and characterization of the drug-binding-defect inducer in uremia.
    Lichtenwalner DM; Suh B; Lorber B; Rudnick MR; Craig WA
    J Lab Clin Med; 1981 Jan; 97(1):72-81. PubMed ID: 7452082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in protein binding during disease.
    Craig WA; Suh B
    Scand J Infect Dis Suppl; 1978; (14):239-44. PubMed ID: 279978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of protein binding defect in uremic sera by charcoal treatment.
    Craig WA; Evenson MA; Sarver KP; Wagnild JP
    J Lab Clin Med; 1976 Apr; 87(4):637-47. PubMed ID: 1270877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Faster estimation of reserve bilirubin binding capacity of serum from the neonate by thin-layer chromatography on sephadex.
    Trivin F; Odièvre M; Lemonnier A
    Clin Chem; 1977 Mar; 23(3):541-5. PubMed ID: 837541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of fatty acids on the binding of bilirubin to albumin.
    Odell GB; Cukier JO; Ostrea EM; Maglalang AC; Poland RL
    J Lab Clin Med; 1977 Feb; 89(2):295-307. PubMed ID: 833468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new HPLC analytical method for o-hydroxyhippuric acid in uremic serum.
    Suh B; Lee HW; Hong SY; Kim S; Eshraghi J; Paik WK
    J Biochem Biophys Methods; 1986 Nov; 13(4-5):211-20. PubMed ID: 3805574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired protein binding of Chinese medicine DanShen in uremic sera and sera with hyperbilirubinemia: rapid assessment of total and free DanShen concentrations using the fluorescence polarization immunoassay for digoxin.
    Wahed A; Pollard J; Wells A; Dasgupta A
    J Clin Lab Anal; 2003; 17(5):179-83. PubMed ID: 12938147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A laboratory investigation into bilirubin binding in neonates.
    Buchanan N; Moodley GP; Strickwold B; Eyberg C; Rothberg AD
    S Afr Med J; 1977 Feb; 51(7):197-9. PubMed ID: 847568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Binding capacity of albumin for bilirubin in neonates].
    Zoban P; Tomásová H; Mydlil V; Karas J; Michková E
    Cesk Pediatr; 1986 Dec; 41(12):719-22. PubMed ID: 3802280
    [No Abstract]   [Full Text] [Related]  

  • 17. Uremic sera contain inhibitors that block digitoxin-valproic acid interaction.
    Dasgupta A; Paul A; Wells A
    Am J Med Sci; 2001 Oct; 322(4):204-8. PubMed ID: 11678517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of a colorimetric and a HPLC method for the determination of serum hippuric acid concentrations in uremia.
    Vanholder R; De Smet R; Schoots A; Ringoir S
    Nephron; 1988; 49(2):164-8. PubMed ID: 3380232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The displacement of albumin bound bilirubin by free fatty acids in vivo.
    Haefliger S; Magnenat P
    Biomedicine; 1978 May; 28(2):109-13. PubMed ID: 580895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship of gestational age to reserve albumin concentration for binding of bilirubin.
    Robertson A; Sharp C; Karp W
    J Perinatol; 1988; 8(1):17-8. PubMed ID: 3236087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.